Flu nose spray vaccine with “live” (weakened) viruses. Not tested with seniors, since it is considered risky. Therefore no data about benefits or risks exists. High risk potential.
Do not use this treatment for seniors:
Nose spray with “live” influenza viruses is considered risky and is not given to seniors. No data about benefits or risks. High risk potential.
Note that the information here relates only to HEALTHY seniors. Flu vaccines are, for example, essential for asthmatic seniors.
Flu nose spray vaccine with “live” (weakened) viruses
healthy Seniors, 65 year old and above
Seasonal vaccine (once a year). One dose. But NOT given to seniors
Prevention of Influenza infection, symptoms and complications.
Unknown. Nose spray with “live” influenza viruses is considered risky and therefore is not tested with seniors.
Unclear. High risk potential. Nose spray with “live” influenza viruses is considered risky and is not given to seniors.
Flu (influenza virus infection and symptoms).
Symptoms and signs:
Cough, dizziness, fever, headache, nausea, pains, runny nose, sore throat, vomiting and aches.
Ear infection, lung infection, Seizures.
Visitors at this page also visited
Flu Nasal Aerosol
Live attenuated influenza vaccine (LAIV) is a type of influenza vaccine in the form of a nasal spray. It is an attenuated vaccine, unlike most influenza vaccines, which are inactivated vaccines. LAIV is administered intranasally, while inactivated vaccines are administered by intramuscular injection. Both live attenuated and inactivated vaccines are typically trivalent, since they contain material from three different influenza virus. LAIV is sold under the trade name FluMist in the United States and Canada. (source)
Similar pages on this site
Good to know
Maher Still ""Not Crazy"" About Vaccinations
HBO's Real Time, 16 October 2009
Sharing as the future of Medicine
Dear Doctors, here is an article about practice challenges you should seriously consider.